Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 4Stage II Prostate Adenocarcinoma 1Adenocarcinoma 1

Interventions

Oxaliplatin 2Fluorouracil 2rubitecan 1nimotuzumab 1halofantrine 1gallium 68 PSMA-11 1camrelizumab 1apatinib 1S 1 (combination) 1Radiotherapy 1Radiosurgery 1Radiation 1Photochemotherapy 1Nadroparin 1Heparin, Low-Molecular-Weight 1Gastrectomy 1Esophagectomy 1Docetaxel 1Cisplatin 1Chemoradiotherapy 1Capecitabine 1CP protocol 1Brachytherapy 1Atrasentan 1Androgen Antagonists 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Adenocarcinoma × gallium 68 PSMA-11 × Clear all
NCT07209878 2025-10-07

68Ga-PSMA-11 PET Imaging for Diagnosing Prostate Cancer, a Head-to-head Comparison With mpMRI

First Affiliated Hospital of Fujian Medical University

Phase 2/3 Recruiting
100 enrolled
Genitourinary

Adenocarcinoma, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡